Ra Pharmaceuticals, Inc.

Candriam S.C.A.

Report date

3/31/2020

Quarter

2020 Q1

Filed

5/26/2020

Shares

99,523

Value ($000)

4,566

Weight

0.1%

2019 Q3 - 2020 Q1 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q1	5/26/2020	4,566	0.1%	99,523	3/31/2020
2019 Q4	2/5/2020	4,671	0.1%	99,523	12/31/2019
2019 Q3	2/5/2020	29,042	0.4%	1,228,000	9/30/2019